BioPharma Translationsinstitut Dessau Forschungs GmbH

Germany

Back to Profile

1-4 of 4 for BioPharma Translationsinstitut Dessau Forschungs GmbH Sort by
Query
Aggregations
IP Type
        Patent 3
        Trademark 1
Jurisdiction
        World 2
        Europe 1
        United States 1
Date
2022 1
2020 2
Before 2020 1
IPC Class
C12N 9/76 - TrypsinChymotrypsin 3
C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA 2
C12N 9/64 - Proteinases derived from animal tissue, e.g. rennin 1
C12Q 1/37 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving hydrolase involving peptidase or proteinase 1
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 1
05 - Pharmaceutical, veterinary and sanitary products 1
42 - Scientific, technological and industrial services, research and design 1
Status
Pending 1
Registered / In Force 3

1.

TRYPSIN VARIANTS WITH IMPROVED ENZYMATIC PROPERTIES

      
Application Number 17416975
Status Pending
Filing Date 2019-12-19
First Publication Date 2022-07-28
Owner BIOPHARMA TRANSLATIONSINSTITUT DESSAU FORSCHUNGS GMBH (Germany)
Inventor
  • Wartner, René
  • Boehme, Marcus
  • Bordusa, Frank
  • Simon, Andreas Hans
  • Richter, Thomas

Abstract

The present invention relates to trypsin variants with improved enzymatic properties, and particularly relates to a mutated trypsin comprising an amino acid substitution at least at two amino acid positions leading to an increased affinity for the nucleophilic substrate and/or at least at two amino acid positions leading to a reduced hydrolysis activity.

IPC Classes  ?

2.

TRYPSIN VARIANTS WITH IMPROVED ENZYMATIC PROPERTIES

      
Application Number EP2019086425
Publication Number 2020/127808
Status In Force
Filing Date 2019-12-19
Publication Date 2020-06-25
Owner BIOPHARMA TRANSLATIONSINSTITUT DESSAU FORSCHUNGS GMBH (Germany)
Inventor
  • Wartner, René
  • Boehme, Marcus
  • Bordusa, Frank
  • Simon, Andreas Hans
  • Richter, Thomas

Abstract

The present invention relates to trypsin variants with improved enzymatic properties, and particularly relates to a mutated trypsin comprising an amino acid substitution at least at two amino acid positions leading to an increased affinity for the nucleophilic substrate and/or at least at two amino acid positions leading to a reduced hydrolysis activity.

IPC Classes  ?

  • C12N 9/64 - Proteinases derived from animal tissue, e.g. rennin
  • C12Q 1/37 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving hydrolase involving peptidase or proteinase
  • C12N 9/76 - TrypsinChymotrypsin
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA

3.

TRYPSIN MUTANT FOR C- AND N-TERMINAL MODIFICATION OF POLYPEPTIDES

      
Application Number EP2019080673
Publication Number 2020/094840
Status In Force
Filing Date 2019-11-08
Publication Date 2020-05-14
Owner BIOPHARMA TRANSLATIONSINSTITUT DESSAU FORSCHUNGS GMBH (Germany)
Inventor
  • Bordusa, Frank
  • Liebscher, Sandra
  • Meyer, Christoph

Abstract

The present invention relates to a mutated trypsin comprising an amino acid substitution both at position K60 and D189, and at least one more amino acid substitution at position Y39 or Y59, having a preferred recognition site TYR-ARG-Xaa-HIS, wherein Xaa is any amino acid.

IPC Classes  ?

  • C12N 9/76 - TrypsinChymotrypsin
  • C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA

4.

TrypCo

      
Application Number 017981343
Status Registered
Filing Date 2018-11-06
Registration Date 2019-04-12
Owner BioPharma Translationsinstitut Dessau Forschungs GmbH (Germany)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Reagents and bioactive compounds for industrial and scientific use. Pharmaceutical preparations for the treatment of human diseases. Biotechnological research and services in relation with enzymatic modification of proteins.